Back

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

27 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Comorbidities and heart failure: cause and effect Comorbidities ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Giuseppe Armentaro

University Hospital Renato Dulbecco, Catanzaro (Italy)

7 More presentations in this session

Presentation thumbnail
Differential effects of heart failure with reduced ejection fraction on locomotor and respiratory muscles
Doctor N. Mangner (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on exercise capacity and functional class in patients with heart failure without systemic iron deficiency or anaemia
Doctor P. Moliner (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on clinical outcomes in patients with heart failure without systemic iron deficiency or anaemia
Miss L. Alcoberro (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on health-related quality of life in patients with heart failure without systemic iron deficiency or anaemia
Doctor P. Moliner (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Physical capacity determines physical and mental health in patients with chronic heart failure - a case control study
Mr S. Winter (Graz, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and heart failure: cause and effect

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.
thumbnail
Congress Presentation
Impact of SGLT2-inhibitors on cardiac function and structural changes in patients with heart failure and reduced ejection fraction - Results from the REWIN-HFrEF Study
thumbnail
Congress Presentation
Sodium-glucose co-transporter-2 inhibitors: prognostic benefit in real-world, elderly, comorbid HFmrEF and HFpEF patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources